Characterization of 5q deletions by subtelomeric probes and spectral karyotyping

Cancer Genetics and Cytogenetics

Volumn 103, Issue 2, 1998, Pages 170-172

  Ning, Yi ^a,c   Liang, Jan C ^b   Nagarajan, Lalitha ^b   Schröck, Evelin ^a   Ried, Thomas ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 5Q; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CYTOGENETICS; GENE DELETION; HUMAN; HUMAN CELL; KARYOTYPING; PRIORITY JOURNAL; SIGNAL DETECTION; TELOMERE;

ACUTE DISEASE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; DNA PROBES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID; MICROSCOPY, FLUORESCENCE; MICROSCOPY, INTERFERENCE; TELOMERE;

EID: 0032102191     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00417-2     Document Type: Article

References (12)

1. Schröck E, du Manoir S, Veldman T, Schoel B, Wienberg J, Ferguson-Smith M, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T (1996): Multicolor spectral karyotyping of human chromosomes. Science 273:494-497.
2. Ning Y, Roschke A, Smith ACM, Macha M, Precht K, Riethman H, Ledbetter DH (group 1), Flint J, Horsley S, Regan R, Kearney L, Knight S, Kvaloy K, Brown WRA (group 2) (1996): A complete set of human telomeric probes and their clinical application. Nat Genet 14:86-89.
3. Heim S, Mitelman F (1995): Cancer Cytogenetics. Wiley-Liss, New York.
4. Mecucci C, Van den Berghe H (1992): Cytogenetics. Hematol Oncol Clin N Am 6:523-541.
5. Boultwood J, Lewis S, Wainscoat JS (1994): The 5q- syndrome. Blood 84:3253-3260.
6. Nagarajan L (1995): Molecular analysis of the 5q- chromosome. Leuk Lymph 17:361-366.
7. Dewald GW, David MP, Pierre RV, O'Fallon JR, Hoagland HC (1985): Clinical characteristics and progress of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5. Blood 66:189-197.
8. Pedersen B, Jensen IM (1991): Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients. Leukemia 5:566-573.
9. Le Beau MM, Espinosa R, Neuman WL, Stock W, Roulston D, Larson RA, Keinanen M, Westbrook CA (1993): Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci U S A 90:5484-5488.
10. Mitelman F (1991): Catalog of Chromosome Aberrations in Cancer. Wiley-Liss, New York.
11. Meltzer PS, Guan XY, Trent JM (1993): Telomere capture stabilizes chromosome breakage. Nat Genet 4:252-255.
12. Veldman T, Vignon C, Schröck E, Rowley JD, Ried T (1997): Hidden chromosomal abnormalities in hematological malignancies detected by multicolor spectral karyotyping. Nat Genet 15:406-410.